rs59110261

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_152732.5(RSPH9):​c.-18A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00778 in 1,606,496 control chromosomes in the GnomAD database, including 830 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.042 ( 465 hom., cov: 32)
Exomes 𝑓: 0.0042 ( 365 hom. )

Consequence

RSPH9
NM_152732.5 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0780

Publications

1 publications found
Variant links:
Genes affected
RSPH9 (HGNC:21057): (radial spoke head component 9) This gene encodes a protein thought to be a component of the radial spoke head in motile cilia and flagella. Mutations in this gene are associated with primary ciliary dyskinesia 12. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Jul 2010]
RSPH9 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 12
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 6-43645081-A-G is Benign according to our data. Variant chr6-43645081-A-G is described in ClinVar as Benign. ClinVar VariationId is 262684.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.141 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RSPH9NM_152732.5 linkc.-18A>G 5_prime_UTR_variant Exon 1 of 5 ENST00000372163.5 NP_689945.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RSPH9ENST00000372163.5 linkc.-18A>G 5_prime_UTR_variant Exon 1 of 5 1 NM_152732.5 ENSP00000361236.4
RSPH9ENST00000372165.8 linkc.-18A>G 5_prime_UTR_variant Exon 1 of 6 2 ENSP00000361238.4

Frequencies

GnomAD3 genomes
AF:
0.0416
AC:
6331
AN:
152080
Hom.:
463
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.144
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0154
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000779
Gnomad OTH
AF:
0.0302
GnomAD2 exomes
AF:
0.0107
AC:
2554
AN:
239164
AF XY:
0.00788
show subpopulations
Gnomad AFR exome
AF:
0.148
Gnomad AMR exome
AF:
0.00838
Gnomad ASJ exome
AF:
0.000912
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000529
Gnomad NFE exome
AF:
0.000468
Gnomad OTH exome
AF:
0.00453
GnomAD4 exome
AF:
0.00423
AC:
6152
AN:
1454298
Hom.:
365
Cov.:
31
AF XY:
0.00369
AC XY:
2674
AN XY:
723850
show subpopulations
African (AFR)
AF:
0.143
AC:
4777
AN:
33430
American (AMR)
AF:
0.00891
AC:
398
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.00146
AC:
38
AN:
26082
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39672
South Asian (SAS)
AF:
0.000290
AC:
25
AN:
86208
European-Finnish (FIN)
AF:
0.0000208
AC:
1
AN:
48148
Middle Eastern (MID)
AF:
0.00503
AC:
29
AN:
5764
European-Non Finnish (NFE)
AF:
0.000294
AC:
326
AN:
1110066
Other (OTH)
AF:
0.00926
AC:
558
AN:
60244
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
303
606
910
1213
1516
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0417
AC:
6345
AN:
152198
Hom.:
465
Cov.:
32
AF XY:
0.0399
AC XY:
2970
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.144
AC:
5984
AN:
41506
American (AMR)
AF:
0.0154
AC:
236
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.000779
AC:
53
AN:
68002
Other (OTH)
AF:
0.0299
AC:
63
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
295
591
886
1182
1477
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0172
Hom.:
65
Bravo
AF:
0.0471
Asia WGS
AF:
0.00779
AC:
27
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Dec 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Primary ciliary dyskinesia 12 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
15
DANN
Benign
0.74
PhyloP100
0.078
PromoterAI
0.53
Over-expression
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs59110261; hg19: chr6-43612818; API